Prognosis of Patients With Infective Endocarditis and Risk Stratification Value of Biomarkers (ENDEAVOR）

Recruiting now

Conditions studied: Infective Endocarditis

In brief

In this study, by establishing a clinical cohort of infective endocarditis, we observed the natural prognosis and influencing factors in the process of disease development and regression; we used multi-omics technology to understand the prognostic value of its biomarkers, and provided new ideas and evidence for the pathogenesis, clinical diagnosis and treatment of IE.

Key facts

Study ID

NCT05965362

Run by

First Affiliated Hospital Xi'an Jiaotong University

People needed

2000

Starts

2024-05-09

Expected to finish

2028-12-31

Last updated by the study team

2024-07-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with clinically confirmed infective endocarditis

You may not qualify if…

• Patients refuse to sign informed consent form
• Patients who combined with serious systemic diseases, cannot tolerate the acquisition of biological samples

Where it is running

• First Affiliated Hospital of Xian Jiantong University — Xi'an, Shaanxi, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.